Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

0.5311
Delayed Data
As of 3:21pm ET
 -0.0042 / -0.78%
Today’s Change
0.26
Today|||52-Week Range
1.16
-16.69%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Revenue and IncomeNet Revenues5.4M8.5M3.4M580.0K
 
 
 
 
 
Cost of Goods Sold546.5K909.5K242.3K0.00
 
 
 
 
Depreciation And Amortization117.8K111.5K122.5K86.5K
 
 
 
 
 
 
Operating ExpensesGross Income4.7M7.5M3.0M493.5K
 
 
 
 
 
General Expenses5.3M4.1M5.4M3.6M
 
 
 
 
 
Research And Development2.5M1.3M2.4M705.3K
 
 
 
 
 
Total Operating Expenses6.0M5.1M5.8M3.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-580.0K3.4M-2.4M-3.1M
 
 
 
 
 
Extraordinary Credit1.5M0.001.1M140.5K
 
 
 
 
Extraordinary Charge0.00-839.3K0.00-1.3M
 
 
 
Pre-Tax Equity Earnings-2.9K0.000.000.00
 
 
Interest Expense On Debt7.5M2.6M2.6M0.00
 
 
 
 
Other Expenses-39.9K-12.5K22.0K-21.6K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-6.7M-59.5K-3.9M-4.3M
 
 
 
 
 
Income Taxes0.000.000.00-1.5M
 
 
Minority Interest-116.00-159.00-132.00-202.00
 
 
 
 
 
Discontinued Operations0.000.000.00-255.9K
 
 
Extraordinary Items0.000.000.0088.7M
 
 
Net Income-6.7M-59.4K-3.9M-3.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS155.4M155.5M155.5M160.4M
 
 
 
 
 
Shares To Calculate EPS Diluted155.4M155.5M155.5M164.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.04$0.00-$0.02$0.52
 
 
 
 
EPS Diluted-$0.04-$0.00-$0.02-$0.02